APA (7th ed.) Citation

Hu, H., Yin, Y., Jiang, B., Feng, Z., Cai, T., & Wu, S. (2023). Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Hu, Hai, Yuesong Yin, Binbin Jiang, Zhennan Feng, Ting Cai, and Song Wu. Cuproptosis Signature and PLCD3 Predicts Immune Infiltration and Drug Responses in Osteosarcoma. Frontiers Media S.A, 2023.

MLA (9th ed.) Citation

Hu, Hai, et al. Cuproptosis Signature and PLCD3 Predicts Immune Infiltration and Drug Responses in Osteosarcoma. Frontiers Media S.A, 2023.